MBS146754 | Recombinant Human Tumor Necrosis Factor Receptor 13B, Sf9

Recombinant Human Tumor Necrosis Factor Receptor 13B, Sf9 | MBS146754 | MyBiosource

Product Short Name: [Tumor Necrosis Factor Receptor 13B]

Product Name Synonyme: [TACI Human, Sf9; Tumor Necrosis Factor Receptor Superfamily Member 13B; Tumor Necrosis Factor Receptor Superfamily; Member 13B; Transmembrane Activator And CAML Interactor;TACI; Tumor Necrosis Factor Receptor 13B; CD267 Antigen; TNFRSF14B; CD267; CVID2; IGAD2; CVID; RYZN; Tumor Necrosis Factor Receptor 13B Human Recombinant, Sf9]

Other Names: [tumor necrosis factor receptor superfamily member 13B; Tumor necrosis factor receptor superfamily member 13B; tumor necrosis factor receptor superfamily member 13B; TNF receptor superfamily member 13B; Transmembrane activator and CAML interactor; CD_antigen: CD267]

Product Gene Name: N/A

Product Gene Name Synonyme: N/A

Other Gene Names: [TNFRSF13B; TNFRSF13B; CVID; RYZN; TACI; CD267; CVID2; IGAD2; TNFRSF14B; TACI]

Clonality: N/A

Isotype: N/A

Clone: N/A

Host: Sf9, Insect cells

Reactivity: N/A

Specificity: N/A

Purity: Greater than 90.0% as determined by SDS-PAGE.

Form: Sterile filtered colorless solution.
TACI a protein solution (0.25mg/ml) contains Phosphate Buffered Saline (pH 7.4), 30% glycerol and 1mM DTT.

Concentration: N/A

Storage Stability: N/A

Tested Application: N/A